Synlogic

About:

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Website: http://synlogictx.com

Twitter/X: synlogic_tx

Top Investors: OrbiMed, Deerfield, Perceptive Advisors, Ginkgo Bioworks, New Enterprise Associates

Description:

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.

Total Funding Amount:

$472M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)synlogictx.com

Founders:

Alison Silva, Ankit Mahadevia, Dean Falb, Jim Collins, Timothy K. Lu

Number of Employees:

51-100

Last Funding Date:

2023-09-29

IPO Status:

Public

© 2025 bioDAO.ai